Kupando
Kupando is a biotech company. It has 2 recorded funding rounds, most recently an Extension Round in March 2026.
Fighting Cancer and Infectious Diseases
- Website
- kupando.com
- Last Round
- Extension RoundMar 2026
- Rounds
- 2
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Kupando – Fighting Cancer and Infectious Diseases. KUPANDO is a pioneering Berlin-based biopharmaceutical company.
Summary
Its most recent funding was an Extension Round in Mar 2026. Investors include Remiges Ventures, Brandenburg Kapital GmbH and High-Tech Grunderfonds.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2026
Sign up to see all 2 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kupando"><img src="https://indexed.vc/api/badge/company/kupando" alt="Kupando on Indexed.vc" width="260" height="76" /></a>